金合欢和刺金合欢中强效抗癌和抗氧化活性化合物的多目标组合对接

Q3 Pharmacology, Toxicology and Pharmaceutics
Yanico Hadi Prayogo, Setyanto Tri Wahyudi, Irmanida Batubara, Rita Kartika Sari, W. Syafii
{"title":"金合欢和刺金合欢中强效抗癌和抗氧化活性化合物的多目标组合对接","authors":"Yanico Hadi Prayogo, Setyanto Tri Wahyudi, Irmanida Batubara, Rita Kartika Sari, W. Syafii","doi":"10.52711/0974-360x.2024.00110","DOIUrl":null,"url":null,"abstract":"Bioactive chemicals derived from Acacia auriculiformis and A. crassicarpa have the potential to be developed as sources of anti-cancer raw materials and antioxidants, given that these plants are fast-growing species with medicinal capability. The in silico method was successful in identifying these bioactive chemicals for the preliminary study. Using an in silico approach, this work aimed to identify the most potent compounds as inhibitors of six cancer and stress oxidative therapy-targeted proteins from these two distinct Acacia species. Seventeen out of the 37 compounds examined exhibited low affinity and satisfied the drug-likeness criterion. Five active chemicals were identified by redocking analysis: auriculoside, 3-(3,4-dihydroxybenzyl)-7-hydroxychroman-4-one, kaempferol 7-O-glucoside, quercetin 7-O-glucoside, and keto-teracacidin. According to simulations of molecular dynamics, molecular motion occurs with a root mean square deviation of less than four and generates at least eleven receptor conformations for 0 to 100 ns. Auriculoside showed the lowest average binding energy against four receptors in colorectal and breast cancer, as determined by ensemble docking, followed by 3-(3,4-dihydroxybenzyl)-7-hydroxychroman-4-one, quercetin 7-O-glucoside, and kaempferol 7-O-glucoside. Auriculoside shown multitarget inhibitory effect against colorectal cancer by inhibiting cyclin dependent kinase-6 and breast cancer by inhibiting epidermal growth factor receptor and mammalian target of rapamycin. Auriculoside has the powerful ability to inhibit glycogen synthase kinase-3 beta, hence regulating oxidative stress. Kaempferol 7-O-glucoside and quercetin 7-O-glucoside also exhibited a possible single protein targeting method against breast cancer. These findings are essential for future research targeted at developing these plants as potent natural therapeutic raw materials and for isolating or synthesizing compounds with anticancer and oxidative stress-regulating antioxidant properties.","PeriodicalId":21141,"journal":{"name":"Research Journal of Pharmacy and Technology","volume":"83 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multitarget Ensemble Docking of Potent Anticancer and Antioxidant Active Compounds from the Acacia auriculiformis and Acacia crassicarpa\",\"authors\":\"Yanico Hadi Prayogo, Setyanto Tri Wahyudi, Irmanida Batubara, Rita Kartika Sari, W. Syafii\",\"doi\":\"10.52711/0974-360x.2024.00110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Bioactive chemicals derived from Acacia auriculiformis and A. crassicarpa have the potential to be developed as sources of anti-cancer raw materials and antioxidants, given that these plants are fast-growing species with medicinal capability. The in silico method was successful in identifying these bioactive chemicals for the preliminary study. Using an in silico approach, this work aimed to identify the most potent compounds as inhibitors of six cancer and stress oxidative therapy-targeted proteins from these two distinct Acacia species. Seventeen out of the 37 compounds examined exhibited low affinity and satisfied the drug-likeness criterion. Five active chemicals were identified by redocking analysis: auriculoside, 3-(3,4-dihydroxybenzyl)-7-hydroxychroman-4-one, kaempferol 7-O-glucoside, quercetin 7-O-glucoside, and keto-teracacidin. According to simulations of molecular dynamics, molecular motion occurs with a root mean square deviation of less than four and generates at least eleven receptor conformations for 0 to 100 ns. Auriculoside showed the lowest average binding energy against four receptors in colorectal and breast cancer, as determined by ensemble docking, followed by 3-(3,4-dihydroxybenzyl)-7-hydroxychroman-4-one, quercetin 7-O-glucoside, and kaempferol 7-O-glucoside. Auriculoside shown multitarget inhibitory effect against colorectal cancer by inhibiting cyclin dependent kinase-6 and breast cancer by inhibiting epidermal growth factor receptor and mammalian target of rapamycin. Auriculoside has the powerful ability to inhibit glycogen synthase kinase-3 beta, hence regulating oxidative stress. Kaempferol 7-O-glucoside and quercetin 7-O-glucoside also exhibited a possible single protein targeting method against breast cancer. These findings are essential for future research targeted at developing these plants as potent natural therapeutic raw materials and for isolating or synthesizing compounds with anticancer and oxidative stress-regulating antioxidant properties.\",\"PeriodicalId\":21141,\"journal\":{\"name\":\"Research Journal of Pharmacy and Technology\",\"volume\":\"83 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research Journal of Pharmacy and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52711/0974-360x.2024.00110\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research Journal of Pharmacy and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52711/0974-360x.2024.00110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

从金合欢和金合欢树中提取的生物活性化学物质具有开发抗癌原料和抗氧化剂来源的潜力,因为这些植物是具有药用价值的快速生长物种。硅学方法成功地为初步研究确定了这些生物活性化学物质。这项研究采用硅学方法,旨在从这两种不同的金合欢属植物中鉴定出最有效的化合物,作为六种癌症和应激氧化疗法靶向蛋白的抑制剂。在研究的 37 种化合物中,有 17 种表现出低亲和性,符合药物相似性标准。通过重新定位分析,确定了五种活性化学物质:枳实苷、3-(3,4-二羟基苄基)-7-羟基色满-4-酮、山柰酚 7-O-葡萄糖苷、槲皮素 7-O-葡萄糖苷和酮-特金合欢苷。根据分子动力学模拟,分子运动的均方根偏差小于 4,在 0 至 100 ns 的时间内至少产生 11 种受体构象。根据集合对接测定,金雀花苷与结直肠癌和乳腺癌中四种受体的平均结合能最低,其次是 3-(3,4-二羟基苄基)-7-羟基色满-4-酮、槲皮素 7-O-葡萄糖苷和山奈酚 7-O-葡萄糖苷。枳壳苷通过抑制细胞周期蛋白依赖性激酶-6,对结直肠癌有多靶点抑制作用;通过抑制表皮生长因子受体和雷帕霉素哺乳动物靶点,对乳腺癌有多靶点抑制作用。枳壳苷具有抑制糖原合成酶激酶-3 beta 的强大能力,从而调节氧化应激。山奈酚 7-O-葡萄糖苷和槲皮素 7-O-葡萄糖苷还展示了一种可能的针对乳腺癌的单一蛋白靶向方法。这些发现对于今后将这些植物开发为有效的天然治疗原料以及分离或合成具有抗癌和氧化应激调节抗氧化特性的化合物的研究至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Multitarget Ensemble Docking of Potent Anticancer and Antioxidant Active Compounds from the Acacia auriculiformis and Acacia crassicarpa
Bioactive chemicals derived from Acacia auriculiformis and A. crassicarpa have the potential to be developed as sources of anti-cancer raw materials and antioxidants, given that these plants are fast-growing species with medicinal capability. The in silico method was successful in identifying these bioactive chemicals for the preliminary study. Using an in silico approach, this work aimed to identify the most potent compounds as inhibitors of six cancer and stress oxidative therapy-targeted proteins from these two distinct Acacia species. Seventeen out of the 37 compounds examined exhibited low affinity and satisfied the drug-likeness criterion. Five active chemicals were identified by redocking analysis: auriculoside, 3-(3,4-dihydroxybenzyl)-7-hydroxychroman-4-one, kaempferol 7-O-glucoside, quercetin 7-O-glucoside, and keto-teracacidin. According to simulations of molecular dynamics, molecular motion occurs with a root mean square deviation of less than four and generates at least eleven receptor conformations for 0 to 100 ns. Auriculoside showed the lowest average binding energy against four receptors in colorectal and breast cancer, as determined by ensemble docking, followed by 3-(3,4-dihydroxybenzyl)-7-hydroxychroman-4-one, quercetin 7-O-glucoside, and kaempferol 7-O-glucoside. Auriculoside shown multitarget inhibitory effect against colorectal cancer by inhibiting cyclin dependent kinase-6 and breast cancer by inhibiting epidermal growth factor receptor and mammalian target of rapamycin. Auriculoside has the powerful ability to inhibit glycogen synthase kinase-3 beta, hence regulating oxidative stress. Kaempferol 7-O-glucoside and quercetin 7-O-glucoside also exhibited a possible single protein targeting method against breast cancer. These findings are essential for future research targeted at developing these plants as potent natural therapeutic raw materials and for isolating or synthesizing compounds with anticancer and oxidative stress-regulating antioxidant properties.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Research Journal of Pharmacy and Technology
Research Journal of Pharmacy and Technology Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
1.40
自引率
0.00%
发文量
0
期刊介绍: Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal, devoted to pharmaceutical sciences. The aim of RJPT is to increase the impact of pharmaceutical research both in academia and industry, with strong emphasis on quality and originality. RJPT publishes Original Research Articles, Short Communications, Review Articles in all areas of pharmaceutical sciences from the discovery of a drug up to clinical evaluation. Topics covered are: Pharmaceutics and Pharmacokinetics; Pharmaceutical chemistry including medicinal and analytical chemistry; Pharmacognosy including herbal products standardization and Phytochemistry; Pharmacology: Allied sciences including drug regulatory affairs, Pharmaceutical Marketing, Pharmaceutical Microbiology, Pharmaceutical biochemistry, Pharmaceutical Education and Hospital Pharmacy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信